🧫
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Validation
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-mhtt-cle
🧫 Experiment Protocol
Validation
Metadata
| experiment_type | validation |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.901512Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['FOXO1/G3BP1/HSPA1A'], 'diseases': ['Neurodegeneration']} |
| model_system | human |
| summary | # Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Validation ## Background and Rationale Huntington's disease (HD) is caused by CAG repeat expansion in the huntingtin gene, producin |
| replication_status | single_study |
| methodology_notes | Phase 1 (Weeks 1-4): Generate human iPSC-derived striatal and cortical neurons from HD patients (n=6 lines, 18-72 CAG repeats) and controls (n=3 lines). Culture neurons for 8-12 weeks to achieve matur |
| primary_outcome | Validate Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Validation |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.901517'} |
🌍 Provenance Graph
11 nodes, 44 edges
derives from (16)
...and 11 more
Linked Artifacts (2671)